This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Rotop Pharmaka Gmbh. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Eik Schiller: Innovator in Diagnostic Radiopharmaceuticals
Introduction
Eik Schiller is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of diagnostic radiopharmaceuticals, particularly with his innovative work on Tetrofosmin. His research focuses on improving the stability and usability of this important compound in medical diagnostics.
Latest Patents
Eik Schiller holds a patent for a "Stabilized form of Tetrofosmin and its use." This invention provides a stabilized form of Tetrofosmin that remains stable at room temperature and in contact with oxygen. The patent also includes a non-radioactive kit containing this stabilized form for preparing a radiopharmaceutical composition. This advancement is particularly beneficial for myocardial perfusion studies in patients with coronary artery diseases and in oncology.
Career Highlights
Eik Schiller is associated with Rotop Pharmaka GmbH, where he continues to develop innovative solutions in the field of pharmaceuticals. His work has been instrumental in enhancing the effectiveness of diagnostic procedures, thereby improving patient outcomes.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Eik Schiller's contributions to the field of diagnostic radiopharmaceuticals exemplify the impact of innovation in medicine. His patented work on Tetrofosmin is a testament to his dedication to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile